133 related articles for article (PubMed ID: 35142182)
1. MicroRNAs: Regulatory Biomarkers in Acute Myeloid Leukemia and Graft Versus Host Disease.
Ramzi M; Shokrgozar N
Clin Lab; 2022 Feb; 68(2):. PubMed ID: 35142182
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
Zhang Y; Zheng H; Ren J; Luo X; Zheng Z; Zheng J; Zheng X; Chen Y; Chen Z; Hu J; Yang T
Hematol Oncol; 2021 Aug; 39(3):380-389. PubMed ID: 33848027
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
[TBL] [Abstract][Full Text] [Related]
4. Identification of Heme Oxygenase-1 as a Novel Predictor of Hematopoietic Stem Cell Transplantation Outcomes in Acute Leukemia.
Lu Y; Wu D; Wang J; Li Y; Ma D; Chai X; Kang Q
Cell Physiol Biochem; 2016; 39(4):1495-502. PubMed ID: 27606430
[TBL] [Abstract][Full Text] [Related]
5. Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation.
Pasic I; Ren AH; Nampoothiri RV; Prassas I; Lipton JH; Mattsson J; Diamandis EP; Michelis FV
Clin Chem Lab Med; 2023 May; 61(6):1005-1014. PubMed ID: 36655501
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy analysis of unrelated donor hematopoietic stem cell transplantation for treatment of high risk acute myeloid leukemia].
Ye F; Tang XW; Sun AN; Qiu HY; Jin ZM; Fu ZZ; Chen F; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):696-701. PubMed ID: 23815925
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as Potential Diagnostic, Prognostic, and Predictive Biomarkers for Acute Graft-versus-Host Disease.
Motaei J; Yaghmaie M; Ahmadvand M; Pashaiefar H; Kerachian MA
Biol Blood Marrow Transplant; 2019 Dec; 25(12):e375-e386. PubMed ID: 31419566
[TBL] [Abstract][Full Text] [Related]
8. Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Medinger M; Heim D; Gerull S; Halter J; Krenger W; Buser A; Lengerke C; Bucher C; Passweg J
Leuk Res; 2016 Aug; 47():22-5. PubMed ID: 27239737
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation].
Chen Y; Xu Y; Zhu Y; Fu G; Liu Y; Peng J; Fu B; He Q; Wu D; Li X; Zhao X; Chen F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):859-64. PubMed ID: 21946205
[TBL] [Abstract][Full Text] [Related]
10. Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.
Ranganathan P; Ngankeu A; Zitzer NC; Leoncini P; Yu X; Casadei L; Challagundla K; Reichenbach DK; Garman S; Ruppert AS; Volinia S; Hofstetter J; Efebera YA; Devine SM; Blazar BR; Fabbri M; Garzon R
J Immunol; 2017 Mar; 198(6):2500-2512. PubMed ID: 28159900
[TBL] [Abstract][Full Text] [Related]
11. Acute graft-versus-host disease in a nonhematopoietic stem cell transplantation candidate treated with decitabine followed by granulocyte colony-stimulating factor-primed peripheral blood stem cells infusion: a special entity of the disease?
Yuan L; Sun L; Yang L; Jing Y
Transfusion; 2014 Jan; 54(1):190-3. PubMed ID: 23621702
[TBL] [Abstract][Full Text] [Related]
12. [HLA-10/10 matched unrelated donor versus sibling donor hematopoietic stem cell transplantation for adult acute myeloid leukemia].
Yao JF; Zhang GX; Shen YY; Zhang RL; He Y; Wei JL; Jiang EL; Yang DL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):460-466. PubMed ID: 31340617
[No Abstract] [Full Text] [Related]
13. [Risk factors analysis for steroid-resistant acute graft versus host disease after haploidentical hematopoietic stem cell transplantation].
Liu WB; Sun YQ; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YY; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ; Mo XD
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):106-111. PubMed ID: 32135625
[No Abstract] [Full Text] [Related]
14. [Plasma MiR-181b and MiR-194 As Biomarkers for Acute Graft- Versus-Host Disease and Significance of Their Changes].
Chen Y; Deng HL; Kang DL; Wang Y; Hong XL; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):957-962. PubMed ID: 34105500
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.
Sang W; Zhang C; Zhang D; Wang Y; Sun C; Niu M; Sun X; Zhou C; Zeng L; Pan B; Chen W; Yan D; Zhu F; Wu Q; Cao J; Zhao K; Chen C; Li Z; Li D; Loughran TP; Xu K
Am J Hematol; 2015 Nov; 90(11):998-1007. PubMed ID: 26223969
[TBL] [Abstract][Full Text] [Related]
16. IFNG-AS1 and MAF4 long non-coding RNAs are upregulated in acute leukemia patients who underwent bone marrow transplantation.
Jafari L; Izadirad M; Vatanmakanian M; Ghaedi H; Farsiani MA; Mohammadi MH; Amiri V; Hosseini MS; Tavakoli F; Azizian R; Gharehbaghian A; Hajifathali A
Curr Res Transl Med; 2021 Oct; 69(4):103307. PubMed ID: 34380104
[TBL] [Abstract][Full Text] [Related]
17. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.
Xiao B; Wang Y; Li W; Baker M; Guo J; Corbet K; Tsalik EL; Li QJ; Palmer SM; Woods CW; Li Z; Chao NJ; He YW
Blood; 2013 Nov; 122(19):3365-75. PubMed ID: 24041574
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Bianchi M; Heim D; Lengerke C; Halter J; Gerull S; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Ann Hematol; 2019 Apr; 98(4):971-977. PubMed ID: 30542943
[TBL] [Abstract][Full Text] [Related]
19. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.
Yin J; Wang C; Huang M; Mao X; Zhou J; Zhang Y
Cancer Med; 2016 Jul; 5(7):1654-69. PubMed ID: 27109254
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Nie DM; Wu QL; Zhu XX; Zhang R; Zheng P; Fang J; You Y; Zhong ZD; Xia LH; Hong M
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):694-699. PubMed ID: 26489624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
